Clinical trial
A Study of JNJ-90301900 in Combination With Concurrent Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT07219212 is registered in ClinicalTrials.gov with Johnson & Johnson Enterprise Innovation Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of JNJ-90301900 in Combination With Concurrent Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma
- Lead sponsor
- Johnson & Johnson Enterprise Innovation Inc.
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- January 26, 2026
- Completion date
- July 14, 2028
- Enrollment
- 45 (estimated)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.